Accredited Investors »

Verve Therapeutics shares owned by Accredited Investors

Quarter-by-quarter ownership of Verve Therapeutics (VERV) shares owned by Accredited Investors from 13F filings

Historical chart of Accredited Investors investment in Verve Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Verve Therapeutics held by Accredited Investors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Verve Therapeutics by Accredited Investors

Quarter filed Position value Share count Share price at filing
2024-03-31 $200k 15k 13.28

More positions owned by Accredited Investors

Ishares Tr Core S&p Mcp Etf (IJH)
United Parcel Service CL B (UPS)
American Centy Etf Tr Intl Smcp Vlu (AVDV)
Ishares Tr Core S&p Scp Etf (IJR)
Ishares Tr Msci Eafe Etf (EFA)
Vanguard Intl Equity Index F Allwrld Ex Us (VEU)
Ishares Tr Core S&p500 Etf (IVV)
Schwab Strategic Tr Us Brd Mkt Etf (SCHB)
1/100 Berkshire Hathaway Cl A
Vanguard Index Fds Value Etf (VTV)
Amazon (AMZN)
Ishares Tr Russell 2000 Etf (IWM)
Roblox Corp Cl A (RBLX)
Spdr Ser Tr Prtflo S&p500 Vl (SPYV)
Apple (AAPL)

View all positions for Accredited Investors

Top funds holding Verve Therapeutics

Alphabet
Vanguard Group
ARK Investment Management
BlackRock
T. Rowe Price Investment Management
Federated Investors
FMR
Casdin Capital
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Arch Venture Corp
Baker Bros. Advisors
Redmile Group
Jpmorgan Chase & Co
Geode Capital Management

View all funds holding Verve Therapeutics